Site:
|
Parapharyngeal space (Prestyloid and retro-styloid)
|
Histology:
|
Salivary neoplasms, neurilemomas, paragangliomas, most
common (80% Benign, 20% Malignant.)
|
Stage:
|
T1-N0 and T2-N0
|
- DIAGNOSTIC EVALUATION
- EXAMINATION UNDER ANESTHESIA AND BIOPSY
- DEFINITIVE AND ADJUVANT TREATMENT
- FOLLOW UP
- BIBLIOGRAPHY
I.DIAGNOSTIC EVALUATION:
Clinical Evaluation:
Parapharyngeal tumors often present as an asymptomatic
mass discovered on routine physical examination or by incidental imaging
studies. Therefore, early detection is difficult.
- Complete history and physical examination
Important historical information includes recording the presence
and duration of pain (throat, neck, headache), sense of throat fullness,
dysphagia, voice change, ear fullness, pressure or hearing loss,
awareness of a parotid area mass or neck mass(es). History of prior
surgery to the head and neck area especially salivary glands, prior
radiation therapy, alcohol, tobacco use, and general medical health
should be obtained.
If on the basis of history or imaging studies a paraganglioma is suspected,
inquire about labile hypertension, tremulousness, headache, pallor, palpitations,
and sweating.
- Complete examination of the head and neck.
Includes careful inspection of the oral cavity and oropharynx
for medial displacement and bulging of the soft palate, tonsil, and
hypopharynx. Bimanual palpation of this area should be done, with
one hand in the pharynx and the other hand below the angle of the
jaw region. Flexible fiberoptic examination of the nasopharynx with
attention to the eustachian tube region, and evaluation of the larynx
and hypopharynx with assessment of vocal cord mobility. Record all
cranial nerve function including palatal deviation (upper X) X, XI,
XII, V2, V3, VII. Carefully palpate the parotid gland, upper neck,
and record size of any masses, consistency, presence of pulsations,
mobility, and presence or absence of other neck masses or adenopathy.
- Biopsy of primary
Transoral biopsy of the tumor prior to surgery should not be performed.
Fine-needle aspiration of prestyloid lesions either transorally or
from the external approach is generally accurate in confirming the
presence of a pleomorphic adenoma. Because of the variety of lesions
encountered in the parapharyngeal space, FNA may augment the initial
assessment, but for retrostyloid lesions often is inconclusive. For
suspected metastatic or primary malignancy, FNA directed by CT or
ultrasound may be helpful.
Imaging Studies:
Radiographic study of all parapharyngeal space tumors is essential.
A computed tomography (CT) scan with contrast medium or a magnetic resonance
imaging (MRI) study with gadolinium should be performed in all cases.
Currently MRI provides the most useful preoperative information with
triplaner views, to determine the tumor's extent, relationship to surrounding
structures, and tumor differentiating characteristics.
Angiography should be done when carotid artery involvement is suspected
or for highly vascular tumors, or tumors that invade the cervical vertebral
bodies or extend to the skull base or intracranially. MR angiography
may replace conventional angiography in many of the above cases.
Carotid occlusion studies must be done if tumor resection is planned
for extensive malignant retrostyloid tumors or extensive vascular tumors
that surround the carotid artery at the skull base.
Laboratory Tests:
Obtain preoperative tests according to institutional guidelines. Tests
to rule out a catecholamine-producing tumor include 24-hour urine collection
for vanillylmandelic acid, metanephrines, dopamine, epinephrine, and
norepinephrine. Serum catecholamines, can also be analyzed.
Consultations:
Interventional neuroradiologist: for consideration of tumor embolization
preoperatively, for extensive paraganglioma and for paragangliomas that
extend intracranially.
Neurosurgeon: for all tumors with intracranial extension or obvious
erosion of the skull base, cervical spine, or extensive vascular lesions,
the combined talents of two surgical disciplines is helpful.
Radiation therapy: for known metastatic tumors or obvious malignant
tumors, postoperative or definitive radiotherapy consultation may be
necessary.
Top
II. EXAMINATION UNDER ANESTHESIA
AND BIOPSY:
Generally this has no role in parapharyngeal tumors with the exception
of metastatic lesions from a head and neck primary site.
Top
III. DEFINITIVE AND ADJUVANT TREATMENT:
Primary tumor:
- Surgery
Definitive statements regarding management of parapharyngeal tumors are
difficult due to the variety and variable extent of tumors encountered
in this area. For the most common lesions, prestyloid salivary pleomorphic
adenomas, an external surgical approach is preferred. This should be done
by an experienced surgeon with an operation that provides adequate tumor
visualization and complete tumor removal with preservation of surrounding
nerves and vessels. The cervical-parotid approach or cervical approach
alone is usually indicated. The need for mandibular osteotomy to assist
exposure is required in less than 20% of cases. This surgical approach
is useful for most lesions encountered in the parapharyngeal space. Decisions
regarding the need to operate on retrostyloid benign tumors should consider
factors such as the patient's age, health, and expected morbidity from
the surgical removal. Observation is the best choice for an asymptomatic
nerve tumor in an elderly patient.
- Radiation
Post-operative radiation is indicated for primary and metastatic malignant
tumors of the parapharyngeal space.
Radiation may be used as primary or palliative treatment of paragangliomas.
- Chemotherapy
Chemotherapy combined with radiation therapy may be considered in malignant
lesions not amenable to surgical excision.
Neck:
- Surgery
A modified or selective neck dissection may be performed for malignant
salivary tumors involving the parapharyngeal space that have a propensity
to spread to regional lymph nodes.
- Radiation
Postoperative radiation can be given to the N0 neck if indicated for the
primary site. For high-risk neck disease determined by clinical or pathologic
findings, (i.e. extracapsular disease, desmoplasia, multiple nodes, low
nodes, atypical metastasis), postoperative radiation therapy is usually
given.
Top
V. FOLLOW UP:
After the removal of most benign tumors, clinical evaluation
and imaging studies should be performed yearly or biannually to rule out
recurrence. Recurrence of benign pleomorphic adenomas can occur up to 20
years, so follow-up at progressively longer intervals should be continued
life?long.
For malignant tumors, the exact frequency of follow-up and testing will depend
on the exact tumor type. In general:
| 1st year |
post-treatment |
post-treatment |
| 2nd year |
post-treatment |
2-4 months |
| 3rd year |
post-treatment |
3-6 months |
| 4th & 5th years |
post-treatment |
6-12 months |
| After 5 years |
post-treatment |
Annually |
Top
VI. BIBLIOGRAPHY:
Olsen, K.D. Tumors & surgery of the parapharyngeal space
? Laryngoscope, Vol. 104 No 5 Part 2 Supplement No. 63 May 1994
Som, P.M., Biller, H.F. and Lawson, W.: Tumors of the Parapharyngeal
Space: Preoperative Evaluation, Diagnosis and Surgical Approaches. Ann Otol
Rhinol Laryngol, 90:3?15, 1981
Gluckman, J.L.: Parapharyngeal Mass, Retrieved May 21, 1999,
from the World Wide Web:
|